Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

ABSTRACT: To investigate safety and tolerance of dose-escalation of infusional recombinant human endostatin in combination with mFOLFOX6 as initial therapy for patients with metastatic colorectal cancer.

DISEASE(S): Colorectal Neoplasm,Colorectal Neoplasms

PROVIDER: 2103392 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR